US equities |
MU $989.04 ▲+0.00% SNDK $1,487.33 ▲+0.00% NVDA $226.32 ▲+0.00% SKHY $162.23 ▲+0.00% UNH $378.52 ▲+0.00% JPM $334.30 ▲+0.00% INTC $101.35 ▲+0.00% META $742.96 ▲+0.00%
FinancialContent

Sunshine Biopharma Inc. - Common stock (NQ:SBFM)

0.3020 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sunshine Biopharma Inc. - Common stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Thursday's session: top gainers and losers ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Which stocks are gapping on Thursday? ↗
Via Chartmill
News headline image
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
Via ACCESS Newswire
Sunshine Biopharma Stock Powers Ahead Following Launch Of Generic Cholesterol-Lowering Drug By Canadian Unit ↗
Via Stocktwits
News headline image
Stocks to Watch: NDRA, SBFM, GOVX, HIVE, ANY Trading Actively NOW!
Via AB Newswire
Topics Artificial Intelligence
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Beats Q1 Expectations, TAEUS® Liver Imaging Advances and Strategic Review Acceleration Fuels Investor Awareness
Via AB Newswire
News headline image
Stocks Under $1: NXXT, TOON, VRAX, AIM, SBFM on Breakout Watch
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
What's going on in today's after hours session ↗
Via Chartmill
Most active stocks in Thursday's session ↗
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
Sunshine Biopharma Stock Rallies On Canadian Approval For Generic Amoxicillin ↗
Sunshine Biopharma (NASDAQ: SBFM) shares are trading higher Thursday after securing Canadian regulatory approval for generic amoxicillin. 
Via Benzinga
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin
Via ACCESS Newswire
Top movers in Wednesday's session ↗
Via Chartmill
BioMedNewsBreaks — Sunshine Biopharma Inc. (NASDAQ: SBFM) Closes $6 Million Public Offering
Via Investor Brand Network
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
News headline image
Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering
Via ACCESS Newswire
News headline image
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
Via ACCESS Newswire
News headline image
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
Via ACCESS Newswire
News headline image
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
Via ACCESS Newswire
News headline image
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
Via ACCESS Newswire
News headline image
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
Via ACCESS Newswire
News headline image
Sunshine Biopharma Stock Is Surging Thursday: Here's What's Happening ↗
Shares of Sunshine Biopharma Inc. (NASDAQ: SBFM) are trading higher Thursday after the Florida-based pharmaceutical company announced the launch of a generic prescription drug. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin
Via ACCESS Newswire
News headline image
Sunshine Biopharma Stock is 34% Higher Since September as Investors Reward Performance Combined with Innovation (NASDAQ: SBFM)
Via AB Newswire
News headline image
Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >